Biotech Danaher to Present at UBS Global and Jefferies Global Healthcare Conferences November 2, 2026
Biotech Rhythm Pharmaceuticals and LG Chem Enter into Amendment to Bivamelagon Exclusive License Agreement November 2, 2026
Biotech Illumina selected to help bring precision medicine into everyday healthcare in Singapore November 2, 2026
Biotech Oculis Appoints Experienced Life Sciences Leader Björn Tackenberg, M.D., Ph.D., as Chief Scientific Officer to Advance Neurology Innovation November 2, 2026
Biotech HUTCHMED Announces Regulatory Filings Accepted for Review for ORPATHYS® plus TAGRISSO® in MET-Driven EGFR-Mutated Lung Cancer in Europe and Japan November 1, 2026
Biotech Intensity Therapeutics to Announce Third Quarter 2026 Financial Results on November 5, 2026 October 31, 2026